Detail Information of Epigenetic Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0183 Transporter Info | ||||
Gene Name | SLC25A22 | ||||
Transporter Name | Mitochondrial glutamate carrier 1 | ||||
Gene ID | |||||
UniProt ID | |||||
Epigenetic Regulations of This DT (EGR) | |||||
---|---|---|---|---|---|
Methylation |
|||||
Atypical teratoid rhabdoid tumor |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A22 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
5'UTR (cg22747142) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.24E+00 | Statistic Test | p-value: 6.48E-06; Z-score: 7.22E-01 | ||
Methylation in Case |
6.70E-01 (Median) | Methylation in Control | 5.38E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A22 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
Body (cg01554951) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.31E+00 | Statistic Test | p-value: 7.42E-05; Z-score: -7.59E-01 | ||
Methylation in Case |
3.58E-01 (Median) | Methylation in Control | 4.68E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A22 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
Body (cg08065122) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.11E+00 | Statistic Test | p-value: 5.30E-03; Z-score: -5.38E-01 | ||
Methylation in Case |
5.54E-01 (Median) | Methylation in Control | 6.14E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC25A22 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
Body (cg13352894) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.98E+00 | Statistic Test | p-value: 3.46E-02; Z-score: -7.07E-01 | ||
Methylation in Case |
9.53E-02 (Median) | Methylation in Control | 1.88E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Breast cancer |
10 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A22 in breast cancer | [ 2 ] | |||
Location |
5'UTR (cg22747142) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.14E+00 | Statistic Test | p-value: 1.34E-03; Z-score: 1.10E+00 | ||
Methylation in Case |
4.35E-01 (Median) | Methylation in Control | 3.83E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A22 in breast cancer | [ 2 ] | |||
Location |
TSS1500 (cg10665488) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.67E+00 | Statistic Test | p-value: 7.88E-09; Z-score: 3.46E+00 | ||
Methylation in Case |
1.45E-01 (Median) | Methylation in Control | 8.71E-02 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A22 in breast cancer | [ 2 ] | |||
Location |
TSS1500 (cg10970251) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.22E+00 | Statistic Test | p-value: 1.40E-05; Z-score: 7.09E-01 | ||
Methylation in Case |
7.54E-02 (Median) | Methylation in Control | 6.18E-02 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC25A22 in breast cancer | [ 2 ] | |||
Location |
TSS1500 (cg07080372) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.23E+00 | Statistic Test | p-value: 1.64E-05; Z-score: 8.95E-01 | ||
Methylation in Case |
1.75E-01 (Median) | Methylation in Control | 1.42E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC25A22 in breast cancer | [ 2 ] | |||
Location |
TSS1500 (cg13749939) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.07E+00 | Statistic Test | p-value: 2.88E-04; Z-score: 2.06E-01 | ||
Methylation in Case |
9.39E-02 (Median) | Methylation in Control | 8.81E-02 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC25A22 in breast cancer | [ 2 ] | |||
Location |
TSS200 (cg16709110) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.06E+00 | Statistic Test | p-value: 1.23E-03; Z-score: -1.93E-01 | ||
Methylation in Case |
5.32E-02 (Median) | Methylation in Control | 5.62E-02 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC25A22 in breast cancer | [ 2 ] | |||
Location |
Body (cg19262958) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.04E+00 | Statistic Test | p-value: 3.42E-06; Z-score: -1.08E+00 | ||
Methylation in Case |
7.79E-01 (Median) | Methylation in Control | 8.13E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC25A22 in breast cancer | [ 2 ] | |||
Location |
Body (cg08065122) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.10E+00 | Statistic Test | p-value: 3.12E-03; Z-score: 1.62E+00 | ||
Methylation in Case |
7.25E-01 (Median) | Methylation in Control | 6.61E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SLC25A22 in breast cancer | [ 2 ] | |||
Location |
Body (cg25211622) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 5.53E-03; Z-score: -2.49E-01 | ||
Methylation in Case |
9.71E-01 (Median) | Methylation in Control | 9.76E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 10 |
Methylation of SLC25A22 in breast cancer | [ 2 ] | |||
Location |
Body (cg26030804) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.06E+00 | Statistic Test | p-value: 4.47E-02; Z-score: 8.91E-01 | ||
Methylation in Case |
9.49E-01 (Median) | Methylation in Control | 8.97E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Colorectal cancer |
13 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A22 in colorectal cancer | [ 3 ] | |||
Location |
5'UTR (cg22747142) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.22E+00 | Statistic Test | p-value: 8.54E-06; Z-score: 1.25E+00 | ||
Methylation in Case |
6.33E-01 (Median) | Methylation in Control | 5.19E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A22 in colorectal cancer | [ 3 ] | |||
Location |
TSS1500 (cg10665488) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.20E+00 | Statistic Test | p-value: 4.92E-08; Z-score: 1.50E+00 | ||
Methylation in Case |
1.99E-01 (Median) | Methylation in Control | 1.66E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A22 in colorectal cancer | [ 3 ] | |||
Location |
TSS1500 (cg10970251) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.06E+00 | Statistic Test | p-value: 2.00E-03; Z-score: 2.39E-01 | ||
Methylation in Case |
8.96E-02 (Median) | Methylation in Control | 8.47E-02 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC25A22 in colorectal cancer | [ 3 ] | |||
Location |
TSS1500 (cg13749939) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.08E+00 | Statistic Test | p-value: 1.78E-02; Z-score: 5.38E-01 | ||
Methylation in Case |
1.41E-01 (Median) | Methylation in Control | 1.31E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC25A22 in colorectal cancer | [ 3 ] | |||
Location |
TSS200 (cg16709110) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 4.71E-02; Z-score: -3.35E-02 | ||
Methylation in Case |
8.48E-02 (Median) | Methylation in Control | 8.53E-02 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC25A22 in colorectal cancer | [ 3 ] | |||
Location |
Body (cg27100471) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.19E+00 | Statistic Test | p-value: 2.95E-04; Z-score: 1.31E+00 | ||
Methylation in Case |
8.83E-01 (Median) | Methylation in Control | 7.41E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC25A22 in colorectal cancer | [ 3 ] | |||
Location |
Body (cg13352894) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.00E+00 | Statistic Test | p-value: 2.43E-03; Z-score: -4.61E-01 | ||
Methylation in Case |
9.42E-01 (Median) | Methylation in Control | 9.47E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC25A22 in colorectal cancer | [ 3 ] | |||
Location |
Body (cg26030804) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.05E+00 | Statistic Test | p-value: 4.34E-03; Z-score: 7.26E-01 | ||
Methylation in Case |
9.81E-01 (Median) | Methylation in Control | 9.34E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SLC25A22 in colorectal cancer | [ 3 ] | |||
Location |
Body (cg19262958) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 7.27E-03; Z-score: -2.05E-01 | ||
Methylation in Case |
8.45E-01 (Median) | Methylation in Control | 8.50E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 10 |
Methylation of SLC25A22 in colorectal cancer | [ 3 ] | |||
Location |
Body (cg20119495) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.00E+00 | Statistic Test | p-value: 8.22E-03; Z-score: -4.26E-01 | ||
Methylation in Case |
9.78E-01 (Median) | Methylation in Control | 9.79E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 11 |
Methylation of SLC25A22 in colorectal cancer | [ 3 ] | |||
Location |
Body (cg08065122) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 2.25E-02; Z-score: -2.82E-01 | ||
Methylation in Case |
8.59E-01 (Median) | Methylation in Control | 8.65E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 12 |
Methylation of SLC25A22 in colorectal cancer | [ 3 ] | |||
Location |
Body (cg17522727) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.12E+00 | Statistic Test | p-value: 4.13E-02; Z-score: 5.14E-01 | ||
Methylation in Case |
9.18E-01 (Median) | Methylation in Control | 8.22E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Hepatocellular carcinoma |
11 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A22 in hepatocellular carcinoma | [ 4 ] | |||
Location |
5'UTR (cg16832267) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 4.73E+00 | Statistic Test | p-value: 2.30E-11; Z-score: 6.74E+00 | ||
Methylation in Case |
3.54E-01 (Median) | Methylation in Control | 7.48E-02 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A22 in hepatocellular carcinoma | [ 4 ] | |||
Location |
5'UTR (cg22747142) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.16E+00 | Statistic Test | p-value: 1.00E-02; Z-score: -8.51E-01 | ||
Methylation in Case |
3.84E-01 (Median) | Methylation in Control | 4.44E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A22 in hepatocellular carcinoma | [ 4 ] | |||
Location |
TSS1500 (cg10665488) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.20E+00 | Statistic Test | p-value: 1.26E-04; Z-score: 1.03E+00 | ||
Methylation in Case |
1.12E-01 (Median) | Methylation in Control | 9.33E-02 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC25A22 in hepatocellular carcinoma | [ 4 ] | |||
Location |
TSS1500 (cg10970251) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.17E+00 | Statistic Test | p-value: 1.55E-03; Z-score: 9.85E-01 | ||
Methylation in Case |
6.40E-02 (Median) | Methylation in Control | 5.48E-02 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC25A22 in hepatocellular carcinoma | [ 4 ] | |||
Location |
TSS1500 (cg07080372) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.13E+00 | Statistic Test | p-value: 2.39E-03; Z-score: 7.32E-01 | ||
Methylation in Case |
1.27E-01 (Median) | Methylation in Control | 1.13E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC25A22 in hepatocellular carcinoma | [ 4 ] | |||
Location |
TSS1500 (cg13749939) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.05E+00 | Statistic Test | p-value: 2.16E-02; Z-score: 2.36E-01 | ||
Methylation in Case |
8.45E-02 (Median) | Methylation in Control | 8.03E-02 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC25A22 in hepatocellular carcinoma | [ 4 ] | |||
Location |
1stExon (cg04643655) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.54E+00 | Statistic Test | p-value: 1.64E-11; Z-score: -2.64E+00 | ||
Methylation in Case |
2.64E-01 (Median) | Methylation in Control | 4.07E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC25A22 in hepatocellular carcinoma | [ 4 ] | |||
Location |
Body (cg19262958) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 2.41E-04; Z-score: -5.92E-01 | ||
Methylation in Case |
8.05E-01 (Median) | Methylation in Control | 8.16E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SLC25A22 in hepatocellular carcinoma | [ 4 ] | |||
Location |
Body (cg13352894) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 1.83E-03; Z-score: -1.79E-01 | ||
Methylation in Case |
8.24E-01 (Median) | Methylation in Control | 8.29E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 10 |
Methylation of SLC25A22 in hepatocellular carcinoma | [ 4 ] | |||
Location |
Body (cg08065122) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.04E+00 | Statistic Test | p-value: 4.96E-03; Z-score: -5.98E-01 | ||
Methylation in Case |
7.44E-01 (Median) | Methylation in Control | 7.71E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 11 |
Methylation of SLC25A22 in hepatocellular carcinoma | [ 4 ] | |||
Location |
3'UTR (cg15600751) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.53E+00 | Statistic Test | p-value: 1.38E-17; Z-score: -3.64E+00 | ||
Methylation in Case |
3.33E-01 (Median) | Methylation in Control | 5.09E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Bladder cancer |
6 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A22 in bladder cancer | [ 5 ] | |||
Location |
TSS1500 (cg10970251) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.02E+00 | Statistic Test | p-value: 3.11E-02; Z-score: 3.04E-01 | ||
Methylation in Case |
5.36E-02 (Median) | Methylation in Control | 5.24E-02 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A22 in bladder cancer | [ 5 ] | |||
Location |
TSS1500 (cg07080372) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -2.06E+00 | Statistic Test | p-value: 3.49E-02; Z-score: -2.87E+00 | ||
Methylation in Case |
9.63E-02 (Median) | Methylation in Control | 1.99E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A22 in bladder cancer | [ 5 ] | |||
Location |
Body (cg08065122) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.41E+00 | Statistic Test | p-value: 5.19E-07; Z-score: -5.94E+00 | ||
Methylation in Case |
5.28E-01 (Median) | Methylation in Control | 7.43E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC25A22 in bladder cancer | [ 5 ] | |||
Location |
Body (cg19262958) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.05E+00 | Statistic Test | p-value: 4.33E-05; Z-score: -4.18E+00 | ||
Methylation in Case |
7.66E-01 (Median) | Methylation in Control | 8.06E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC25A22 in bladder cancer | [ 5 ] | |||
Location |
Body (cg27100471) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.22E+00 | Statistic Test | p-value: 3.42E-03; Z-score: -2.22E+00 | ||
Methylation in Case |
6.82E-01 (Median) | Methylation in Control | 8.32E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC25A22 in bladder cancer | [ 5 ] | |||
Location |
Body (cg25211622) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.03E+00 | Statistic Test | p-value: 3.58E-03; Z-score: -2.57E+00 | ||
Methylation in Case |
9.50E-01 (Median) | Methylation in Control | 9.80E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Renal cell carcinoma |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A22 in clear cell renal cell carcinoma | [ 6 ] | |||
Location |
TSS1500 (cg07080372) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -2.80E+00 | Statistic Test | p-value: 4.42E-12; Z-score: -3.99E+00 | ||
Methylation in Case |
1.29E-01 (Median) | Methylation in Control | 3.60E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A22 in clear cell renal cell carcinoma | [ 6 ] | |||
Location |
TSS1500 (cg10970251) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -6.94E+00 | Statistic Test | p-value: 1.93E-05; Z-score: -2.29E+00 | ||
Methylation in Case |
1.80E-02 (Median) | Methylation in Control | 1.25E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A22 in clear cell renal cell carcinoma | [ 6 ] | |||
Location |
TSS1500 (cg10665488) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -2.82E+00 | Statistic Test | p-value: 6.13E-05; Z-score: -2.32E+00 | ||
Methylation in Case |
6.73E-02 (Median) | Methylation in Control | 1.90E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC25A22 in clear cell renal cell carcinoma | [ 6 ] | |||
Location |
Body (cg19262958) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 5.28E-03; Z-score: -6.33E-01 | ||
Methylation in Case |
9.26E-01 (Median) | Methylation in Control | 9.45E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Colon cancer |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A22 in colon adenocarcinoma | [ 7 ] | |||
Location |
TSS1500 (cg24924779) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 2.70E+00 | Statistic Test | p-value: 1.14E-08; Z-score: 4.80E+00 | ||
Methylation in Case |
5.52E-01 (Median) | Methylation in Control | 2.05E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A22 in colon adenocarcinoma | [ 7 ] | |||
Location |
TSS1500 (cg21168134) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.23E+00 | Statistic Test | p-value: 2.38E-05; Z-score: -3.14E+00 | ||
Methylation in Case |
6.14E-01 (Median) | Methylation in Control | 7.58E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A22 in colon adenocarcinoma | [ 7 ] | |||
Location |
Body (cg23530596) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.40E+00 | Statistic Test | p-value: 1.19E-05; Z-score: -2.83E+00 | ||
Methylation in Case |
3.94E-01 (Median) | Methylation in Control | 5.52E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC25A22 in colon adenocarcinoma | [ 7 ] | |||
Location |
Body (cg07185041) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.23E+00 | Statistic Test | p-value: 8.37E-04; Z-score: -1.57E+00 | ||
Methylation in Case |
4.45E-01 (Median) | Methylation in Control | 5.48E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
HIV infection |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A22 in HIV infection | [ 8 ] | |||
Location |
TSS1500 (cg10665488) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.11E+00 | Statistic Test | p-value: 4.82E-03; Z-score: 4.77E-01 | ||
Methylation in Case |
1.23E-01 (Median) | Methylation in Control | 1.11E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A22 in HIV infection | [ 8 ] | |||
Location |
TSS1500 (cg07080372) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.27E+00 | Statistic Test | p-value: 3.48E-02; Z-score: -1.05E+00 | ||
Methylation in Case |
1.55E-01 (Median) | Methylation in Control | 1.98E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A22 in HIV infection | [ 8 ] | |||
Location |
Body (cg01554951) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.01E+00 | Statistic Test | p-value: 2.49E-02; Z-score: 2.16E-01 | ||
Methylation in Case |
8.82E-01 (Median) | Methylation in Control | 8.73E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC25A22 in HIV infection | [ 8 ] | |||
Location |
Body (cg08065122) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.01E+00 | Statistic Test | p-value: 3.48E-02; Z-score: 3.21E-01 | ||
Methylation in Case |
8.83E-01 (Median) | Methylation in Control | 8.72E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Pancretic ductal adenocarcinoma |
9 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A22 in pancretic ductal adenocarcinoma | [ 9 ] | |||
Location |
TSS1500 (cg25260865) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.32E+00 | Statistic Test | p-value: 1.02E-08; Z-score: -1.58E+00 | ||
Methylation in Case |
2.19E-01 (Median) | Methylation in Control | 2.90E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A22 in pancretic ductal adenocarcinoma | [ 9 ] | |||
Location |
TSS1500 (cg21566348) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.24E+00 | Statistic Test | p-value: 8.36E-05; Z-score: -7.36E-01 | ||
Methylation in Case |
1.13E-01 (Median) | Methylation in Control | 1.40E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A22 in pancretic ductal adenocarcinoma | [ 9 ] | |||
Location |
TSS1500 (cg01053714) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.05E+00 | Statistic Test | p-value: 9.88E-04; Z-score: -6.22E-01 | ||
Methylation in Case |
6.58E-01 (Median) | Methylation in Control | 6.93E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC25A22 in pancretic ductal adenocarcinoma | [ 9 ] | |||
Location |
TSS200 (cg24869640) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.34E+00 | Statistic Test | p-value: 4.87E-11; Z-score: 1.40E+00 | ||
Methylation in Case |
1.07E-01 (Median) | Methylation in Control | 8.00E-02 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC25A22 in pancretic ductal adenocarcinoma | [ 9 ] | |||
Location |
Body (cg05275995) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.11E+00 | Statistic Test | p-value: 5.86E-09; Z-score: -1.53E+00 | ||
Methylation in Case |
6.85E-01 (Median) | Methylation in Control | 7.60E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC25A22 in pancretic ductal adenocarcinoma | [ 9 ] | |||
Location |
Body (cg22305346) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.04E+00 | Statistic Test | p-value: 6.70E-06; Z-score: 1.04E+00 | ||
Methylation in Case |
8.76E-01 (Median) | Methylation in Control | 8.39E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC25A22 in pancretic ductal adenocarcinoma | [ 9 ] | |||
Location |
Body (cg07185425) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.03E+00 | Statistic Test | p-value: 9.56E-05; Z-score: -5.82E-01 | ||
Methylation in Case |
8.32E-01 (Median) | Methylation in Control | 8.55E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC25A22 in pancretic ductal adenocarcinoma | [ 9 ] | |||
Location |
Body (cg05658173) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.11E+00 | Statistic Test | p-value: 4.12E-04; Z-score: 1.58E+00 | ||
Methylation in Case |
7.73E-01 (Median) | Methylation in Control | 6.99E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SLC25A22 in pancretic ductal adenocarcinoma | [ 9 ] | |||
Location |
Body (cg07010687) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.10E+00 | Statistic Test | p-value: 2.14E-02; Z-score: 6.04E-01 | ||
Methylation in Case |
7.29E-01 (Median) | Methylation in Control | 6.61E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Papillary thyroid cancer |
8 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A22 in papillary thyroid cancer | [ 10 ] | |||
Location |
TSS1500 (cg07080372) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.72E+00 | Statistic Test | p-value: 7.03E-18; Z-score: -2.57E+00 | ||
Methylation in Case |
2.63E-01 (Median) | Methylation in Control | 4.52E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A22 in papillary thyroid cancer | [ 10 ] | |||
Location |
TSS1500 (cg10970251) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -2.22E+00 | Statistic Test | p-value: 3.84E-14; Z-score: -1.90E+00 | ||
Methylation in Case |
4.76E-02 (Median) | Methylation in Control | 1.06E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A22 in papillary thyroid cancer | [ 10 ] | |||
Location |
TSS1500 (cg10665488) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.53E+00 | Statistic Test | p-value: 1.49E-10; Z-score: -2.18E+00 | ||
Methylation in Case |
2.03E-01 (Median) | Methylation in Control | 3.11E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC25A22 in papillary thyroid cancer | [ 10 ] | |||
Location |
TSS1500 (cg13749939) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.50E+00 | Statistic Test | p-value: 2.81E-08; Z-score: -1.34E+00 | ||
Methylation in Case |
5.24E-02 (Median) | Methylation in Control | 7.83E-02 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC25A22 in papillary thyroid cancer | [ 10 ] | |||
Location |
Body (cg19262958) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.03E+00 | Statistic Test | p-value: 9.47E-09; Z-score: -1.36E+00 | ||
Methylation in Case |
8.63E-01 (Median) | Methylation in Control | 8.88E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC25A22 in papillary thyroid cancer | [ 10 ] | |||
Location |
Body (cg17522727) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.01E+00 | Statistic Test | p-value: 3.93E-04; Z-score: 7.19E-01 | ||
Methylation in Case |
9.30E-01 (Median) | Methylation in Control | 9.19E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC25A22 in papillary thyroid cancer | [ 10 ] | |||
Location |
Body (cg13352894) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 5.36E-03; Z-score: -6.33E-01 | ||
Methylation in Case |
8.95E-01 (Median) | Methylation in Control | 9.10E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC25A22 in papillary thyroid cancer | [ 10 ] | |||
Location |
Body (cg27100471) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.06E+00 | Statistic Test | p-value: 6.04E-03; Z-score: 1.84E+00 | ||
Methylation in Case |
8.94E-01 (Median) | Methylation in Control | 8.47E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Systemic lupus erythematosus |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A22 in systemic lupus erythematosus | [ 11 ] | |||
Location |
TSS1500 (cg13749939) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.03E+00 | Statistic Test | p-value: 1.60E-03; Z-score: -1.78E-01 | ||
Methylation in Case |
1.07E-01 (Median) | Methylation in Control | 1.11E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus [ ICD-11: 4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A22 in systemic lupus erythematosus | [ 11 ] | |||
Location |
Body (cg25211622) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.00E+00 | Statistic Test | p-value: 3.97E-02; Z-score: -7.16E-03 | ||
Methylation in Case |
9.83E-01 (Median) | Methylation in Control | 9.84E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus [ ICD-11: 4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A22 in systemic lupus erythematosus | [ 11 ] | |||
Location |
Body (cg08065122) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 4.31E-02; Z-score: -2.68E-01 | ||
Methylation in Case |
8.79E-01 (Median) | Methylation in Control | 8.88E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus [ ICD-11: 4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Lung adenocarcinoma |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A22 in lung adenocarcinoma | [ 12 ] | |||
Location |
Body (cg26030804) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.05E+00 | Statistic Test | p-value: 4.99E-03; Z-score: 1.14E+00 | ||
Methylation in Case |
9.58E-01 (Median) | Methylation in Control | 9.12E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A22 in lung adenocarcinoma | [ 12 ] | |||
Location |
Body (cg27100471) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.12E+00 | Statistic Test | p-value: 3.03E-02; Z-score: 1.47E+00 | ||
Methylation in Case |
8.51E-01 (Median) | Methylation in Control | 7.60E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A22 in lung adenocarcinoma | [ 12 ] | |||
Location |
Body (cg17522727) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.06E+00 | Statistic Test | p-value: 3.08E-02; Z-score: 8.91E-01 | ||
Methylation in Case |
9.30E-01 (Median) | Methylation in Control | 8.78E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Panic disorder |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A22 in panic disorder | [ 13 ] | |||
Location |
Body (cg19262958) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.16E+00 | Statistic Test | p-value: 2.09E-03; Z-score: 6.99E-01 | ||
Methylation in Case |
2.29E+00 (Median) | Methylation in Control | 1.98E+00 (Median) | ||
Studied Phenotype |
Panic disorder [ ICD-11: 6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Prostate cancer |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A22 in prostate cancer | [ 14 ] | |||
Location |
Body (cg17550582) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.17E+00 | Statistic Test | p-value: 3.89E-02; Z-score: -1.52E+00 | ||
Methylation in Case |
4.55E-02 (Median) | Methylation in Control | 5.32E-02 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Cerebral hemispheric glioma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Moderate hypomethylation of SLC25A22 in cerebral hemispheric glioma than that in healthy individual | ||||
Studied Phenotype |
Cerebral hemispheric glioma [ICD-11:2A00.5] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value: 0.005458332; Fold-change: -0.243761747; Z-score: -0.761061802 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples | |||||
microRNA |
|||||
Unclear Phenotype |
44 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
miR-1-3p directly targets SLC25A22 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-1-3p | miRNA Mature ID | miR-1-3p | ||
miRNA Sequence |
UGGAAUGUAAAGAAGUAUGUAU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 2 |
miR-1207 directly targets SLC25A22 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-1207 | miRNA Mature ID | miR-1207-5p | ||
miRNA Sequence |
UGGCAGGGAGGCUGGGAGGGG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 3 |
miR-1224 directly targets SLC25A22 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-1224 | miRNA Mature ID | miR-1224-5p | ||
miRNA Sequence |
GUGAGGACUCGGGAGGUGG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 4 |
miR-1227 directly targets SLC25A22 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-1227 | miRNA Mature ID | miR-1227-5p | ||
miRNA Sequence |
GUGGGGCCAGGCGGUGG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 5 |
miR-124 directly targets SLC25A22 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-124 | miRNA Mature ID | miR-124-5p | ||
miRNA Sequence |
CGUGUUCACAGCGGACCUUGAU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 6 |
miR-15a directly targets SLC25A22 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-15a | miRNA Mature ID | miR-15a-5p | ||
miRNA Sequence |
UAGCAGCACAUAAUGGUUUGUG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 7 |
miR-15b directly targets SLC25A22 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-15b | miRNA Mature ID | miR-15b-5p | ||
miRNA Sequence |
UAGCAGCACAUCAUGGUUUACA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 8 |
miR-16 directly targets SLC25A22 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-16 | miRNA Mature ID | miR-16-5p | ||
miRNA Sequence |
UAGCAGCACGUAAAUAUUGGCG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 9 |
miR-1909 directly targets SLC25A22 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-1909 | miRNA Mature ID | miR-1909-3p | ||
miRNA Sequence |
CGCAGGGGCCGGGUGCUCACCG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 10 |
miR-1915 directly targets SLC25A22 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-1915 | miRNA Mature ID | miR-1915-3p | ||
miRNA Sequence |
CCCCAGGGCGACGCGGCGGG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 11 |
miR-195 directly targets SLC25A22 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-195 | miRNA Mature ID | miR-195-5p | ||
miRNA Sequence |
UAGCAGCACAGAAAUAUUGGC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 12 |
miR-1972 directly targets SLC25A22 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-1972 | miRNA Mature ID | miR-1972 | ||
miRNA Sequence |
UCAGGCCAGGCACAGUGGCUCA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 13 |
miR-203b directly targets SLC25A22 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-203b | miRNA Mature ID | miR-203b-3p | ||
miRNA Sequence |
UUGAACUGUUAAGAACCACUGGA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 14 |
miR-206 directly targets SLC25A22 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-206 | miRNA Mature ID | miR-206 | ||
miRNA Sequence |
UGGAAUGUAAGGAAGUGUGUGG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 15 |
miR-3915 directly targets SLC25A22 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-3915 | miRNA Mature ID | miR-3915 | ||
miRNA Sequence |
UUGAGGAAAAGAUGGUCUUAUU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 16 |
miR-3928 directly targets SLC25A22 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-3928 | miRNA Mature ID | miR-3928-3p | ||
miRNA Sequence |
GGAGGAACCUUGGAGCUUCGGC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 17 |
miR-4260 directly targets SLC25A22 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4260 | miRNA Mature ID | miR-4260 | ||
miRNA Sequence |
CUUGGGGCAUGGAGUCCCA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 18 |
miR-4453 directly targets SLC25A22 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4453 | miRNA Mature ID | miR-4453 | ||
miRNA Sequence |
GAGCUUGGUCUGUAGCGGUU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 19 |
miR-4489 directly targets SLC25A22 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4489 | miRNA Mature ID | miR-4489 | ||
miRNA Sequence |
UGGGGCUAGUGAUGCAGGACG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 20 |
miR-4514 directly targets SLC25A22 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4514 | miRNA Mature ID | miR-4514 | ||
miRNA Sequence |
ACAGGCAGGAUUGGGGAA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 21 |
miR-4538 directly targets SLC25A22 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4538 | miRNA Mature ID | miR-4538 | ||
miRNA Sequence |
GAGCUUGGAUGAGCUGGGCUGA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 22 |
miR-4632 directly targets SLC25A22 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4632 | miRNA Mature ID | miR-4632-5p | ||
miRNA Sequence |
GAGGGCAGCGUGGGUGUGGCGGA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 23 |
miR-4650 directly targets SLC25A22 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4650 | miRNA Mature ID | miR-4650-5p | ||
miRNA Sequence |
UCAGGCCUCUUUCUACCUU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 24 |
miR-4660 directly targets SLC25A22 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-4660 | miRNA Mature ID | miR-4660 | ||
miRNA Sequence |
UGCAGCUCUGGUGGAAAAUGGAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 25 |
miR-4685 directly targets SLC25A22 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4685 | miRNA Mature ID | miR-4685-5p | ||
miRNA Sequence |
CCCAGGGCUUGGAGUGGGGCAAGGUU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 26 |
miR-4689 directly targets SLC25A22 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4689 | miRNA Mature ID | miR-4689 | ||
miRNA Sequence |
UUGAGGAGACAUGGUGGGGGCC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 27 |
miR-4726 directly targets SLC25A22 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-4726 | miRNA Mature ID | miR-4726-3p | ||
miRNA Sequence |
ACCCAGGUUCCCUCUGGCCGCA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 28 |
miR-4763 directly targets SLC25A22 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4763 | miRNA Mature ID | miR-4763-3p | ||
miRNA Sequence |
AGGCAGGGGCUGGUGCUGGGCGGG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 29 |
miR-486 directly targets SLC25A22 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-486 | miRNA Mature ID | miR-486-3p | ||
miRNA Sequence |
CGGGGCAGCUCAGUACAGGAU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 30 |
miR-5006 directly targets SLC25A22 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-5006 | miRNA Mature ID | miR-5006-5p | ||
miRNA Sequence |
UUGCCAGGGCAGGAGGUGGAA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 31 |
miR-6085 directly targets SLC25A22 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-6085 | miRNA Mature ID | miR-6085 | ||
miRNA Sequence |
AAGGGGCUGGGGGAGCACA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 32 |
miR-613 directly targets SLC25A22 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-613 | miRNA Mature ID | miR-613 | ||
miRNA Sequence |
AGGAAUGUUCCUUCUUUGCC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 33 |
miR-665 directly targets SLC25A22 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-665 | miRNA Mature ID | miR-665 | ||
miRNA Sequence |
ACCAGGAGGCUGAGGCCCCU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 34 |
miR-6721 directly targets SLC25A22 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-6721 | miRNA Mature ID | miR-6721-5p | ||
miRNA Sequence |
UGGGCAGGGGCUUAUUGUAGGAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 35 |
miR-6722 directly targets SLC25A22 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-6722 | miRNA Mature ID | miR-6722-3p | ||
miRNA Sequence |
UGCAGGGGUCGGGUGGGCCAGG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 36 |
miR-6735 directly targets SLC25A22 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-6735 | miRNA Mature ID | miR-6735-5p | ||
miRNA Sequence |
CAGGGCAGAGGGCACAGGAAUCUGA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 37 |
miR-6736 directly targets SLC25A22 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-6736 | miRNA Mature ID | miR-6736-3p | ||
miRNA Sequence |
UCAGCUCCUCUCUACCCACAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 38 |
miR-6764 directly targets SLC25A22 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-6764 | miRNA Mature ID | miR-6764-5p | ||
miRNA Sequence |
UCCCAGGGUCUGGUCAGAGUUG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 39 |
miR-6813 directly targets SLC25A22 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-6813 | miRNA Mature ID | miR-6813-5p | ||
miRNA Sequence |
CAGGGGCUGGGGUUUCAGGUUCU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 40 |
miR-6837 directly targets SLC25A22 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-6837 | miRNA Mature ID | miR-6837-5p | ||
miRNA Sequence |
ACCAGGGCCAGCAGGGAAUGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 41 |
miR-6840 directly targets SLC25A22 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-6840 | miRNA Mature ID | miR-6840-3p | ||
miRNA Sequence |
GCCCAGGACUUUGUGCGGGGUG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 42 |
miR-6858 directly targets SLC25A22 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-6858 | miRNA Mature ID | miR-6858-5p | ||
miRNA Sequence |
GUGAGGAGGGGCUGGCAGGGAC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 43 |
miR-6879 directly targets SLC25A22 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-6879 | miRNA Mature ID | miR-6879-5p | ||
miRNA Sequence |
CAGGGCAGGGAAGGUGGGAGAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 44 |
miR-7843 directly targets SLC25A22 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-7843 | miRNA Mature ID | miR-7843-5p | ||
miRNA Sequence |
GAGGGCAGAGCCAGCUUCCUGA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.